Clinical Trial Results:
A RANDOMIZED, COMPARATIVE,CONTROLLED PHASE III, MULTICENTER STUDY OF HEXVIX FLUORESCENCE CYSTOSCOPY ANDWHITE LIGHT CYSTOSCOPY IN THE DETECTION OF PAPILLARY BLADDER CANCER AND THE EARLYRECURRENCE RATE IN PATIENTS WITH BLADDER CANCER
Summary
|
|
EudraCT number |
2004-002259-15 |
Trial protocol |
AT |
Global completion date |
31 Jul 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
31 Oct 2020
|
First version publication date |
31 Oct 2020
|
Other versions |
|
Summary report(s) |
A randomized, comparative, controlled Phase III, multicentre study of Hexvix fluorescence cystoscopy and white light cystoscopy in detection of papillary bladder cancer and the early recurrence |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.